UK probing Novo’s Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughts
The MHRA said that two other GLP-1 drugs, Sanofi's lixisenatide and Eli Lilly's dulaglutide, were also included. Sanofi and Lilly did not immediately respond to requests for comment on Wednesday.
GLP-1 receptor agonists were originally…